The NICR published the research result of “The Influence of Alcohol on the Risk and Survival of Head and Neck Cancer
” (Sci Rep. 2017 Aug 29;7(1):9701). The article was reported in No. 819 of NHRI Communications (Chinese Version).
NICR established the Cell-based Therapeutic Unit in collaboration with the National Cheng Kung University Hospital on Sep. 26, 2019. The article was reported in No. 812 of NHRI Communications (Chinese Version).
The NICR published the research result of “Nanoliposomal irinotecan with 5-fluorouracil and leucovorin in metastatic pancreatic cancer after prior gemcitabine-based therapy (NAPOLI-1): a global, randomized, open-label phase 3 trial. ” (Lancet 2016 Feb;387(10018):545-57). The article was reported in No. 631 of NHRI Communications (Chinese Version).
